Receptos looks to raise $75M

Receptos (RCPT) has made a filing to offer up to $75M worth of stock. The firm closed at $28.75 on Tuesday.

SA author Stephen Simpson made the pharmaceutical company an Alpha-Rich pick in mid-August, since when its share price has shot up almost 100%.

"I was attracted by the company's S1P1 modulator technology and the prospects of the lead drug RPC1063 in both multiple sclerosis and ulcerative colitis," writes Simpson.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs